Navigation Links
Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer
Date:11/5/2010

the proposed transaction, Clarient's ability to continue to develop and expand its diagnostic services business, uncertainties inherent in Clarient's product development programs, Clarient's ability to attract and retain highly qualified managerial, technical, and sales and marketing personnel, Clarient's ability to maintain compliance with financial and other covenants under its credit facility, Clarient's ability to successfully manage its in-house billing and collections processes, the continuation of favorable third-party payor reimbursement for laboratory tests, changes in federal payor regulations or policies, including adjustments to Medicare reimbursement rates, that may affect coverage and reimbursement for Clarient's laboratory diagnostics services, Clarient's ability to obtain additional financing on acceptable terms or at all, unanticipated expenses or liabilities or other adverse events affecting cash flow, uncertainty of success in identifying, developing and commercializing new diagnostic tests or novel markers including the Mammostrat(R) test, Clarient's ability to fund development of new diagnostic tests and novel markers, and to obtain adequate patent protection covering Clarient's use of these tests and markers including for the Mammostrat(R) test, and the amount of resources Clarient determines to apply to novel marker development and commercialization, the risk to Clarient of infringement claims and the possibility of the need to license intellectual property from third parties to avoid or settle such claims, failure to obtain regulatory approvals and clearances required to conduct clinical trials if/when required and/or to commercialize Clarient's services and underlying diagnostic applications, Clarient's ability to compete with other technologies and with emerging competitors in novel cancer diagnostics and dependence on third parties for collaboration in developing new tests, and risks detailed from time to time in Clarient's SEC reports, in
'/>"/>
SOURCE Clarient, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Omeros Appoints David A. Mann to its Board of Directors
2. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
3. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
4. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
5. Regenesis Biomedical Announces Additions to Board of Directors
6. GM Exec Joins Bio-Reaction Industries Board of Directors
7. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
8. SulphCo Adds New Board Member
9. Landauer, Inc. Appoints Two New Members to Board of Directors
10. Resverlogix Board of Directors Update
11. MedQuist Announces Additions to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... WIEN , July 3, 2015 /PRNewswire/ ... fram till 22 september 2015 på  http://www.openinnovationinscience.at ... Open Innovation in Science" som hålls i ... Enligt en färsk undersökning med internationella forskare ... Gesellschaft (LBG) är hälsovetenskapens två största utmaningar ...
(Date:7/3/2015)... July 3, 2015  Pomerantz LLP announces that a ... Inc. ("Puma" or the "Company")(NYSE: PBYI ) and ... United States District Court, Central District of ... behalf of a class consisting of all persons or ... and May 13, 2015 inclusive (the "Class Period").  This ...
(Date:7/2/2015)... ... ... Cuvettes have been used in countless labs for decades. In the past, people had ... As expected, this was a daunting and tiring process looking at endless data tables and ... to navigate the complex catalog structure. , Now thanks to FireflySci, scientists are throwing away ...
(Date:7/2/2015)... BETHESDA, Md. , July 2, 2015  Spherix ... committed to the fostering and monetization of intellectual property, ... matter of Spherix Incorporated v. Verizon Services Corp. ... States District Court for the Eastern District of ... Order on July 1, 2015 interpreting certain key claims ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4New Cuvette E-Commerce Website Launched by FireflySci 2Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3
... of World Kidney Day, Kibow Biotech, Inc. is pleased ... the worldwide maintenance of healthy kidney function among all ... addition, Kibow Biotech, Inc. would also like to announce ... for conducting human clinical trials with its patented, proprietary ...
... Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today ... pivotal trial of pixantrone for the treatment of diffuse ... Food and Drug Administration,s (the "FDA") Division of Hematologic ... to as the PIX-R or PIX 306 trial, will ...
... is a black box. A complex circuitry of neurons ... of a computer chip. But while computer processors are ... neural circuits are impenetrable masses. Think tumbleweed. Researchers ... a technique for unraveling these masses. Through a combination ...
Cached Biology Technology:Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease 2Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease 3FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 2FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 3FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 4FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 5Web-crawling the brain 2Web-crawling the brain 3
(Date:6/16/2015)... 16, 2015 /CNW Telbec/ - handyem Inc. and ... the incorporation of handyem,s HPC-150 portable flow cytometer ... Mo-POD™. This unprecedented model of mobile laboratory platform ... the Pennsylvania Convention Center, ... th to 18 th 2015.  By ...
(Date:6/15/2015)... -- According to a new market research ... and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... The Natural Language Processing Market is expected to grow ... the forecast period 2015-2020. Browse 65 ... spread   through 155 P ages and in-depth ...
(Date:6/11/2015)... , June 11, 2015 Daon, a ... today that its IdentityX Mobile Authentication Platform v4.0 ... Online) Alliance is an industry consortium launched in ... for simpler, stronger authentication.  In order to receive ... a rigorous series of tests that measure compliance ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
... receiving an honour, the American entertainer Jack Benny once said, ... I don,t deserve that either." Unfortunately, Benny was not ... Arthritis is associated with significant discomfort and simple activities such ... painful. A variety of treatments are available, usually involving ...
... Zoological Society of London (ZSL) are requesting that the ... commercial road through the world,s best known wildlife sanctuarySerengeti ... can meet the transportation needs of the region without ... in the world. At issue is the proposed ...
... of Puerto Rico may provide researchers valuable information about ... spill. University of Central Florida biologist John Fauth, ... agencies are studying the threatened Elkhorn Coral in the ... most of the area appears healthy, some coral are ...
Cached Biology News:A dog's life -- physiotherapy for arthritic pets 2Commercial road would disrupt world's greatest migration 2Coral off Puerto Rico's coast 'ideal case study' for Gulf oil spill's impact 2
... is optimized for maximum packaging efficiencies of cDNA ... l vector. Using a test insert with Novagen's ... (> 4 x 10^8 pfu/g ligated l control ... extremely easy to use; simply add up to ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
BD BioCoat Laminin 150 mm Culture Dishes...
Polymerase (RNA) II (DNA directed) polypeptide L...
Biology Products: